Polycystic Ovary Syndrome
International evidence-based guidelines include 166 recommendations and practice points to improve health outcomes of women with PCOS.
Investigators examine the influence of gender, sex hormones, and obesity on the composition of gut microbiota in women with PCOS.
Serum chemerin may serve as a biomarker to identify pregnant women with polycystic ovary syndrome who are at particular risk for later abortion, and who may benefit from prevention strategies.
Metformin treatment during pregnancy did not influence the metabolic profile in women with polycystic ovary syndrome at 7.7 years of follow-up.
These data confirmed the increased risk for psychiatric disorders in women with PCOS, and indicated an increased risk for ADHD and ASD in their children.
Researchers evaluated the association between PCOS and psychiatric outcomes, as well as whether rates of autism spectrum disorder and attention-deficit/hyperactivity disorder are higher in children of mothers with PCOS.
Metformin treatment during pregnancy may improve outcomes in women with polycystic ovary syndrome.
Children exposed to metformin had higher BMI and increased prevalence of overweight/obesity at 4 years of age.
Variable improvements in menses, hormones, and metabolism were seen during 24 months of metformin use in 119 women with PCOS sub-grouped by baseline weight and androgen status.
Study evaluated the difference in the rate of ongoing pregnancy or live birth between frozen embryo transfer and fresh embryo transfer in women without polycystic ovary syndrome who were undergoing IVF.
While hirsutism may indicate metabolic abnormalities, acne and androgenic alopecia are associated with other clinical hyperandrogenism manifestations.
Among women with polycystic ovary syndrome, type two diabetes was more common and diagnosed at a younger age than in control groups.
Two studies examined the efficacy of acupuncture therapy for stress incontinence and PCOS, finding mixed results.
Data from a systematic review and meta-analysis confirmed a higher risk of anxiety and depression in PCOS, but underlying factors are still unclear.
The highest prevalence of metabolic syndrome in women with polycystic ovary syndrome in the United States occurred in black women.
Researchers examined the efficacy of combination SPIOMET therapy vs oral contraceptive for reducing ectopic fat and restoring normalized ovulation in adolescents with PCOS.
In a follow-up to the PregMet study, researchers examined the long-term metabolic effects of metformin therapy in pregnancy with polycystic ovarian syndrome.
An international survey shows that women with polycystic ovary syndrome are dissatisfied with the information they receive and the length of time to diagnosis.
Resveratrol decreased levels of adrenal and ovarian androgens in women with polycystic ovary syndrome.
Women experienced weight loss as well as decreases in ovarian volume and markers of androgen excess.
For women with polycystic ovary syndrome (PCOS) seeking infertility treatment, the use of frozen embryos rather than fresh appears to improve the chances for a successful pregnancy.
Soy isoflavones were associated with lower levels of circulating insulin and biological markers of insulin resistance in polycystic ovary syndrome.
The diagnosis and management of polycystic ovary syndrome (PCOS) was discussed in a case vignette published in The New England Journal of Medicine.
A portion of women with polycystic ovary syndrome may experience excess adrenal hormone production.
Four randomized controlled trials show benefits for metformin and oral contraceptive pills.
Risk for asthma was increased by 34% in women with polycystic ovary syndrome.
Researchers concluded that including androstenedione in the diagnosis of biochemical hyperandrogenism led to a prevalence of hyperandrogenic PCOS of more than 80%.
Analyses of 3 databases show use for metabolic syndrome, PCOS, and obesity.
Preconception interventions designed to induce weight loss in women with PCOS improved metabolic parameters and ovulation rates.
Children born to mothers with polycystic ovary syndrome may be more likely to have autism spectrum disordes
Endocrinology Advisor Articles
- Relationship Between HbA1c and Coronary Artery Disease
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women
- FDA Approves First Mobile App for Use in Preventing Pregnancy
- Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation
- Treating Painful Diabetic Peripheral Neuropathy With Electroacupuncture